XOMA Reports Fourth Quarter and Full-Year 2019 Financial Results and Operating Highlights Mar 10, 2020 7:30am EDT
Zydus and XOMA Announce IL-2-Based Immuno-Oncology Therapy Licensing Agreement Mar 09, 2020 5:00am EDT
XOMA Reports Third Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results Nov 05, 2019 8:20am EST
